BSE filing, NSE: AMITINT. Summary written from the filing by ALFA Finder's alert engine.
More from Amit International Ltd
All →Amit International Other Announcement
Amit International Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing discloses the promoter and public shareholding details.
Amit International Annual General Meeting
Amit International Limited held its 32nd Annual General Meeting on September 29, 2026, where members voted on various resolutions, including financial adoption and director appointments.
Amit International Annual General Meeting
Amit International Limited issued the notice for its 32nd Annual General Meeting to be held on September 29, 2026, including details on e-voting facilities.
Amit International Board Meeting Outcome
Amit International approved the notice for its 32nd AGM and appointed a new Secretarial Auditor and a Statutory Auditor to fill a casual vacancy.
Amit International Board Meeting Date
Amit International Limited has scheduled a board meeting for September 5, 2026, to discuss the upcoming 32nd Annual General Meeting and appoint auditors.
Amit International Management Change
Amit International Limited announced the resignation of its statutory auditor, M/s Vinod S. Mehta & Co., effective 14th August 2026 due to internal restructuring.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.